ABSTRACT
This chapter provides a much-needed synthesis and a helpful analysis of this emerging field, which has yet to assume its definitive form. It talk about nanotechnology that has new diagnostic techniques involving the analysis of biomolecules, and targeted therapies and techniques for drug-delivery since contributed to a range of associated domains classified under the heading of personalized medicine, including high-volume sequencing. Indeed, convergence between personalized medicine and nanomedicine (NM) has become one of the explicit political objectives of health and technology policy, as people can see in the vision paper published by the European Technology Platform on Nanomedicine in 2005, where they present three priority domains—diagnostics, drug delivery, and regenerative medicine—under the global heading of personalized medicine. In this context, NM is seen as a transversal research field that promises to revolutionize healthcare, with some seeing it as the means to arrive at making human enhancement a reality.
